Ono, Taisuke <br/><br/>
Curcumin ameliorates skeletal muscle atrophy in type 1 diabetic mice by inhibiting protein ubiquitination.  [electronic resource] 

 -  Experimental physiology  Sep 2015 
 - 1052-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1469-445X 
<br/><br/><label>Standard No.: </label>10.1113/EP085049  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antioxidants--metabolism<br/>Body Weight--drug effects<br/>Curcumin--pharmacology<br/>Diabetes Mellitus, Experimental--drug therapy<br/>Diabetes Mellitus, Type 1--drug therapy<br/>Gene Expression--drug effects<br/>Insulin--metabolism<br/>Interleukin-1beta--metabolism<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Muscle Proteins--metabolism<br/>Muscle, Skeletal--drug effects<br/>Muscular Atrophy--drug therapy<br/>NF-kappa B--metabolism<br/>Oxidative Stress--drug effects<br/>SKP Cullin F-Box Protein Ligases--metabolism<br/>Signal Transduction--drug effects<br/>Tripartite Motif Proteins<br/>Tumor Necrosis Factor-alpha--metabolism<br/>Ubiquitin-Protein Ligases--metabolism<br/>Ubiquitination--drug effects